Gilead Sciences completes $21bn acquisition of Immunomedics: A new era in cancer treatment

pharmanewsdaily- October 24, 2020 0

Gilead Sciences, a leading US-based pharmaceutical giant, has successfully concluded its $21 billion acquisition of Immunomedics, a New Jersey-based biopharmaceutical company renowned for its advancements ... Read More

Gilead acquisition of Immunomedics : Pharma giant to gain access to breast cancer drug Trodelvy

pharmanewsdaily- September 14, 2020 0

Gilead acquisition of Immunomedics : US pharma giant Gilead Sciences has signed a $21 billion worth deal to acquire New Jersey-based biopharma company Immunomedics to ... Read More